Beijing Wantai Biological Pharmacy News and Activities

Beijing Wantai Biological Pharmacy is one of the...

• CSI 300;
• TOB Iconic 10,000.

Beijing Wantai Biological Pharmacy is a company listed under the stock ticker 603392 (CN).

View the org chart displaying its 11 main executives

Most searched biographies at Beijing Wantai Biological Pharmacy

• Zhiming Jiang, General Manager, Director
• Xin Qiu Zi, Chairman of the Board
• Hui Qiang Xing, Independent Director

Create your alert
to follow the executive moves at Beijing Wantai Biological Pharmacy.

Beijing Wantai Biological Pharmacy has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Beijing Wantai Biological Pharmacy

Social media about Beijing Wantai Biological Pharmacy

• Beijing Wantai Biological Pharmacy on Wikipedia, Google News & Yahoo Finance
• Beijing Wantai Biological Pharmacy on LinkedIn, X (Twitter) & YouTube